Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Association between glutamate transporter gene polymorphisms and obsessive-compulsive disorder/trait empathy in a Korean population

  • Hae Won Kim,

    Roles Conceptualization, Formal analysis, Investigation, Writing – original draft, Writing – review & editing

    Affiliations Department of Medical Education, Yonsei University College of Medicine, Seoul, Republic of Korea, Institute of Behavioral Science in Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea

  • Jee In Kang,

    Roles Conceptualization, Formal analysis, Investigation, Supervision

    Affiliations Institute of Behavioral Science in Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea, Department of Psychiatry, Yonsei University College of Medicine, Seoul, Republic of Korea

  • Eun Hee Hwang,

    Roles Data curation, Formal analysis, Investigation, Project administration

    Affiliation Institute of Behavioral Science in Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea

  • Se Joo Kim

    Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Supervision, Writing – original draft, Writing – review & editing

    kimsejoo@yuhs.ac

    Affiliations Institute of Behavioral Science in Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea, Department of Psychiatry, Yonsei University College of Medicine, Seoul, Republic of Korea

Abstract

Accumulating evidence suggests that the glutamatergic system plays a major role in the pathophysiology of obsessive compulsive disorder (OCD) and empathic processing. Particularly, genetic influence of glutamate transporter gene (SLC1A1) on OCD has been frequently replicated in previous studies, but several studies did not replicate the result. Therefore, we aimed to replicate the associations between the SLC1A1 and OCD in a Korean population. In addition, we investigated the influence of SLC1A1 on trait empathy, impairments in which are characteristic of OCD. Six single-nucleotide polymorphisms (SNP) of SLC1A1 were genotyped in 615 patients with OCD and 508 healthy controls. The interpersonal reactivity index (IRI)—which consists of four subscales (perspective taking, PT; fantasy seeking, FS; empathic concern, EC; personal distress, PD)—was assessed from 277 patients with OCD and 395 controls. There were no significant associations between OCD and SNPs or haplotypes of SLC1A1. Patients with OCD exhibited significantly lower PT and higher PD scores than controls. The C-T-G haplotype at rs301430-rs301434-rs3087879 of SLC1A1 was significantly associated with higher PD scores after adjusted for age, sex, and OCD status. Our results suggest that six common SNPs of SLC1A1 may not contribute to the development of OCD, but may contribute to certain aspect of trait empathy such as personal distress. However, insufficient sample size and limited number of SLC1A1 SNPs may have reduced the likelihood of detecting significant associations. Therefore, further studies with larger sample size and more tag SNPs of the SLC1A1 gene were warranted.

Introduction

Although the causes of obsessive compulsive disorder (OCD) are not fully understood, accumulating evidence indicates that the underlying bases of OCD are neurochemical [1]. To date, the serotonin hypothesis is the most prevailing theory regarding the underlying mechanisms of OCD [2]. However, approximately 40% of patients with OCD exhibit an inadequate response to serotonin reuptake inhibitors (SRIs), and functional abnormality of the serotonin system is not always observed in patients with OCD [1]. In addition, research has demonstrated that the serotonin system is closely interrelated with other neurotransmitter systems in the brain [1], indicating that other neurotransmitters may play a role in the pathophysiology of OCD. Recently, several lines of evidence have suggested that alterations in glutamate neurotransmission also contribute to OCD pathophysiology. Magnetic resonance spectroscopy (MRS) studies have implicated dysregulation of glutamate neurotransmission in cortico-striatal-thalamo-cortical circuits in OCD [3]. Additional studies have reported increased levels of glutamate in the cerebrospinal fluid of patients with OCD [4]. Furthermore, the potential therapeutic benefits of some glutamate modulating agents such as memantine [5], N-acetyl cysteine, riluzole [6], and ketamine [7] have been demonstrated in patients with OCD.

Based on the aforementioned evidence, researchers have suggested that genes associated with glutamate neurotransmission may represent the genetic basis of OCD. Among them, SLC1A1—which encodes glutamate transporter EAAC1—has received particular attention because several linkage studies have suggested that the 9p24 region, at which SLC1A1 lies, may contain a susceptibility gene for OCD [8,9]. To date, several studies have investigated the association between SLC1A1 single nucleotide polymorphisms (SNP) and OCD. Four studies reported a positive association between SLC1A1 and OCD in single SNP analyses [1013], while three additional studies reported a significant association between SLC1A1 and OCD in haplotype analyses, but not in single SNP analyses [1416]. However, one study found no significant association between two SNPs of SLC1A1 and OCD, although a significant influence of SNPs on fluoxetine response was observed [17]. A meta-analysis comprising 815 trios, 306 patients with OCD, and 634 controls found no significant influences of SLC1A1 (nine SNPs) on OCD [18]. These inconsistent findings suggest that additional independent studies are needed. Moreover, to our knowledge, no study has been conducted using subjects of Korean descent regarding the relationship between SLC1A1 variants and primary OCD, except for studies related to antipsychotics-induced obsessive-compulsive symptoms in schizophrenia [19,20].

Lack of empathy has been regarded as a characteristic trait of OCD [21,22]. Empathy refers to the ability to understand and share others’ emotional states in reference to oneself [23]. Pino et al. [24] suggested that OCD is associated with deficits in understanding the mental and emotional states of others and difficulty sharing in the negative emotional experiences of others. Other studies have also reported that patients with OCD exhibit higher levels of personal distress [21,22], empathic concern [21], and lower perspective taking [22] than controls when trait empathy is measured using the interpersonal reactivity index (IRI). Empathic traits are highly heritable [25], and several studies have suggested that various genes such as oxytocin receptor gene (OXTR) [26,27], serotonin receptor gene (HTR2A) [28], or brain-derived neurotrophic factor gene (BDNF) [29] influence IRI. Because several MRS studies have suggested that the glutamatergic system is associated with empathy [30,31], genes associated with glutamate neurotransmission such as SLC1A1 represent potential candidates for genetic markers of trait empathy.

Therefore, the present study aimed (1) to replicate the association between SLC1A1 and OCD in a sample of Korean OCD probands and controls, and (2) to determine the influence of SLC1A1 on trait empathy as measured using the IRI.

Materials and methods

Participants

A total of 615 (man 398, woman 217; mean age 29.9±10.7) unrelated patients with OCD were recruited from Yonsei University Severance Hospital. All patients with OCD were diagnosed using the Structured Clinical Interview and met Axis I criteria specified in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) [32]. Patients with a lifetime history of any psychotic symptoms, mental retardation, comorbid alcohol or other substance use disorders within the last 6 months, or a history of severe organic or neurologic disorders were excluded. A total of 508 healthy, unrelated individuals (man 286, woman 222; mean age 22.2±2.7) were recruited via community advertisements. All participants were of Korean descent according to their home language and self-identified as being of Korean descent. The institutional review board of Severance Hospital approved the study protocol, and written informed consent was obtained from all participants.

Measurements

The severity of symptoms in patients with OCD were assessed using the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) [33]. The severity of depressive symptoms was assessed using the Montgomery-Asberg Depression Rating Scale (MADRS) [34]. Trait empathy was measured using the IRI [35], which contains 28-items scored on a 5-point Likert scale ranging from “Does not describe me well” to “Describes me very well”. The IRI contains four subscales: (1) Perspective Taking (PT), which measures the tendency to adopt the psychological viewpoints of others; (2) Fantasy (FS), which measures the tendency to imagine and identify with fictional characters such as those from books or movies; (3) Empathic Concern (EC), which measures the tendency to experience "other-oriented" feelings of sympathy and concern for the misfortune of others; (4) Personal Distress (PD), which measures the tendency to have "self-oriented" feelings of personal anxiety, discomfort, and unease in tense interpersonal settings [35]. The PD and EC scales assess affective components, whereas the PT scale assesses cognitive components. We used the Korean version of the IRI in the present study [36].

SNP selection and genotyping

Among all variants of SLC1A1, we selected six SNPs (rs2228622, rs3780412, rs301430, rs301434, rs3087879, rs301443) that have been most frequently examined in previous studies and often associated with OCD and/or obsessive-compulsive symptoms in single-marker or haplotype analyses [1017,19,20,3740]. Genomic DNA was extracted from blood or saliva. Genotyping was performed using single-base primer extension assay (ABI PRISM SNaPShot Multiplex kit, ABI, Foster City, CA).

Statistical analyses

Differences in demographic and clinical data between patients and controls were examined using Chi-square (χ2) association tests for categorical variables, while t-tests or multivariate analyses of variance (ANOVA) were used for continuous variables. Differences in the allelic distribution of the six SLC1A1 SNPs were examined using χ2 tests. Associations between each SNP genotype and OCD status were examined using age- and sex-adjusted multivariate logistic regression analyses. The genetic model was assumed as additive (i.e., genotypes were coded as 0, 1, and 2 based on the minor allele count). Single-marker analyses were performed using the R package SNPassoc [41]. In haplotype analyses, haplotype blocks of the six SLC1A1 SNPs were defined based on the ‘solid spine of linkage disequilibrium (LD)’ approach in the control sample using Haploview v4.0 [42]. Associations between haplotype distributions and OCD under additive model were examined using the ‘haplo.score’ function of R package haplo.stats [43], while adjusting for age and sex.

In order to analyze the relationship between SLC1A1 variants and certain aspects of empathy measured with IRI, we used all available IRI data that were collected from both OCD and control groups. Therefore, we included disease status (affected vs. unaffected) as a covariate, as well as age and sex, in the analyses of IRI data. The influences of each SNP genotype on the four subscale scores of IRI were examined by multivariate logistic regression analyses adjusted for age, sex, and OCD status. The influence of haplotype on each IRI subscale score was examined using the ‘haplo.score’ function, with adjustment for age, sex, and OCD status.

For single-marker analyses, correction for multiple comparisons of the six SNPs was performed by Bonferroni method. Therefore, the level of statistical significance was set at p<0.0083 (0.05/6) for single SNP analysis. For haplotype analyses, permutation adjustments were performed (n = 100,000), and simulated p<0.05 was regarded as significant.

The statistical power necessary to identify an association with OCD in the present study was calculated as 84.1–99.7% using Quanto software (version 1.2.4; http://biostats.usc.edu/software), based on the minor allele frequency, a genotype relative risk of 1.5 under the assumption of a log-additive model, and a disease prevalence of 2% [44,45].

Results

Demographic and clinical characteristics

The demographic and clinical characteristics of patients with OCD and controls are listed in Table 1. Patients with OCD were significantly older (t = 17.29, p<0.001) and more frequently male (χ2 = 8.28, p = 0.002) than controls. Therefore, we used age and sex as covariates in subsequent analyses. The IRI was assessed from 277 patients with OCD and 395 controls. Patients with OCD exhibited significantly lower PT (F = 5.37, p = 0.02) and higher PD (F = 103.18, p<0.001) scores on the IRI than controls.

thumbnail
Table 1. Socio-demographic and clinical characteristics of the study sample.

https://doi.org/10.1371/journal.pone.0190593.t001

Association between SLC1A1 SNPs and OCD status

No SNP data deviated from Hardy–Weinberg equilibrium in the control group (S1 Table). There were no significant associations between allele/genotype of the six SNPs and OCD status (Table 2). In haplotype analyses, two haplotype blocks were identified: block 1 (rs2228622, rs3780412) and block 2 (rs301430, rs301434, rs3087879) (S1 Fig). There were no significant differences in the distribution of block 1 or block 2 haplotype frequencies between the OCD and control groups (Table 3). Considering that significantly different sex ratios between the two groups might have influenced results, we repeated these analyses in male and in female samples separately. However, the results remained unchanged (S2S5 Tables).

thumbnail
Table 2. Distribution of allelic and genotypic frequencies of SLC1A1 SNPs between OCD and controls.

https://doi.org/10.1371/journal.pone.0190593.t002

thumbnail
Table 3. The effects of SLC1A1 haplotype on affected status of OCD.

https://doi.org/10.1371/journal.pone.0190593.t003

Influences of SLC1A1 SNPs on IRI

In single SNP analyses, nominally significant associations were observed between rs301443 and PT (p = 0.046), rs3780412 and FS (p = 0.044), rs2228622 and PD (p = 0.034), and rs3780412 and PD (p = 0.016) (S6S9 Tables). However, the significance of these associations disappeared after adjusting for multiple comparisons. In haplotype analyses, the C-T-G haplotype in block 2 (rs301430-rs301434-rs3087879) was significantly associated with higher PD scores (Hap-score = 2.0427, crude p = 0.0411, simulated p = 0.0419) (Table 4). However, none of the remaining haplotypes in blocks 1 and 2 exhibited any associations with PT, FS, or EC scores on the IRI (S10S12 Tables). When the single-marker and haplotype analyses were repeated separately for male and female participants, the association between C-T-G haplotype in block 2 and PD score was no longer significant (data not shown).

thumbnail
Table 4. The effects of SLC1A1 haplotype on personal distress score of IRI.

https://doi.org/10.1371/journal.pone.0190593.t004

Discussion

In the present study, we identified no significant associations between six SNPs or haplotypes of SLC1A1 and OCD in a sample of Korean probands and controls. SLC1A1 has received attention as a promising candidate gene for OCD, as two independent studies have suggested a linkage between OCD and 9p24, on which SLC1A1 is located [8,9]. Several subsequent association studies have demonstrated a significant association between SLC1A1 and OCD. A family-based association study involving 87 patients with early-onset OCD and their parents reported significant associations of rs3780412, rs301430, and the T-C haplotype at rs301430-rs301979 with OCD (in the whole sample and in men but not in women) [11]. Arnold et al. [10] performed a family-based association study involving 157 patients with OCD and 319 of their first-degree relatives, reporting significant associations between OCD and rs301434, rs301435, and rs3087879 SNPs of SLC1A1. The authors of this previous study further reported that the C-G haplotype of rs301434-rs3087879 was positively associated with OCD in male offspring. A family-based association study by Stewart et al. [14] involving 66 patients with OCD and their families further reported that the A-T-T haplotype of rs12682807-rs2072657-rs301430 was significantly over-transmitted to offspring with OCD, whereas no single SNPs were associated with OCD. In addition, Shugart et al. [12] performed a family-based association study of 13 SLC1A1 SNPs in a large sample consisting of 1,950 participants across 378 families (1,006 patients with definite or probable OCD), demonstrating an association between rs301433 and OCD under the dominant model. Wu et al. [16] conducted a case-control study involving 578 patients with OCD and 649 controls among the Han Chinese population. In their study, the G-A-C-G and G-G-T-C haplotypes of rs10491734-rs2228622-rs301430-rs301443 were significantly associated with OCD, although no differences in the distributions of genotypes or alleles for individual SNPs were observed between the OCD and control groups.

Despite such evidence, other studies have reported no influence of SLC1A1 on OCD. Samuels et al. [13] conducted a family-based association study of 111 SNPs in or near SLC1A1. Although several SNPs and a haplotype were nominally significantly associated with OCD, those associations were not significant after correction for multiple comparisons. A recent meta-analysis with 815 trios, 306 patients with OCD, and 634 controls also reported no significant association between SLC1A1 (nine SNPs) and OCD [18]. Furthermore, Zhang et al. [17] found no association between SLC1A1 (rs3780412, rs301430) and OCD (OCD, n = 340 and control, n = 350). A case-control study involving patients of the Han Chinese population also reported no association between rs301430 or rs3780412 of SLC1A1 and OCD [17]. Our findings are in accordance with these studies, suggesting a lack of association between SLC1A1 SNPs and OCD. This discrepancy between the positive findings of previous studies and our results may be due to differences in the genotype distributions of SLC1A1 between individuals of European descent and those of Korean descent. For example, Stewart et al. [14] reported a minor allele frequency of 0.43 for rs2228622, whereas this value was 0.23 in the present study (controls). In addition, most studies reporting a positive association between SLC1A1 and OCD were family-based design, whereas the present study utilized a case-control design. Another possible explanation for this discrepancy is that the haplotypes and LD structure of our study were not identical to those used in previous studies due to differences in the ethnic background of the sample and genotyped SNPs of SLC1A1. Indeed, the particular SNPs of SLC1A1 reported to be associated with OCD are not entirely consistent among studies [10,11,13,14]. Furthermore, in contrast to our study, some previous studies reporting positive associations utilized less conservative methods of correction (e.g., permutations) [10] or failed to perform correction for multiple comparisons [11], potentially leading to false-positive associations. In addition, such inconsistencies regarding the association between SLC1A1 and OCD may be due to the underlying genetic heterogeneity of OCD.

In the present study, patients with OCD had significantly lower PT and higher PD scores than controls, even after adjusting for age and sex. These findings suggested that patients with OCD exhibit impairments in the ability to spontaneously consider another’s point of view, as well as emotions in response to observing extreme distress in others [35]. Although we mainly aimed to compare IRI scores between the OCD and control groups, our findings of lower PT and higher PD scores in the OCD group are mostly consistent with those of previous studies [21,22]. Interestingly, we observed that the C-T-G haplotype at rs301430-rs301434-rs3087879 of SLC1A1 was associated with higher PD scores. To our knowledge, the present study is the first to report a genetic influence of SLC1A1 on trait empathy as measured using the IRI. Although no previous studies have examined the association between SLC1A1 and empathy, several lines of evidence support the involvement of the glutamatergic system in empathy. One fMRI-MRS study suggested that glutamatergic modulation of emotional processing is critical for inducing feelings of empathy [30]. Another MRS study reported that glutamate concentration in the dorsolateral prefrontal cortex is negatively correlated with PT score on the IRI [31]. Two genetic studies have also demonstrated an influence of the SLC1A1 gene on autism, which is also characterized by a lack of empathy. A family-based association study involving 86 trios with autism suggested that the T-G haplotype at rs301430-rs301979 is negatively associated with autism (recessive model) [46], while a subsequent study reported that the C allele of rs301430 was associated with more severe anxiety in patients with autism spectrum disorder [47]. One neuroimaging study demonstrated that PD was positively correlated with grey matter volume of the anterior insula and negatively correlated with that in the somatosensory cortex [48]. Research has indicated that glutamate levels in the anterior insula play a major role in emotional processing, and that impairments in glutamate transmission within this region are associated with alexithymia [49]. These findings suggest that SLC1A1 is associated with trait empathy. However, considering that PD represents affective empathy rather than cognitive empathy, our finding regarding the association between certain haplotypes of SLC1A1 and PD may be counterintuitive. Therefore, our results should be regarded as preliminary, as further large-scale studies are required to draw more definitive conclusions.

Several limitations of the present study should be addressed. First, controls were not matched with OCD patients in terms of their age and sex. Although the analyses were adjusted for these demographic factors and reanalysis stratified by sex did not reveal significant sex-specific associations, the possibility of confounding effect could not be completely excluded. Second, while our sample size was relatively larger than those of previous studies that examined associations between SLC1A1 SNPs and OCD, that statistical power of our study findings may not be sufficient for detecting significant associations. Particularly, as IRI was only assessed in a subset of participants, statistical power to find significant relationships between SLC1A1 variants and IRI scores could have been further reduced and results may have been biased. Hence, results regarding the associations between SLC1A1 and IRI should be interpreted with caution. Third, all tag SNPs fully covering the SLC1A1 gene were not included in this study. Although the variants genotyped in this study have been mostly replicated for their associations with OCD and/or obsessive-compulsive symptoms in literature, other variants of SLC1A1 may be associated with OCD and/or trait empathy in a Korean population. Therefore, we could not draw a clear conclusion regarding the relationship between SLC1A1 and OCD in a Korean population. Fourth, we did not rule out the possible confounding effects of population substructure, although Korean population is known to be relatively genetically homogeneous. Nonetheless, although we observed no associations between SNPs of SLC1A1 and OCD in individuals of Korean descent, our findings indicate that a certain haplotype of SLC1A1 was associated with PD scores, as measured using the IRI. Further studies involving larger sample sizes should investigate a larger number SNPs for the SLC1A1 gene.

Supporting information

S1 Fig. Linkage disequilibrium (LD) patterns and haplotype blocks estimated with markers that were examined in this study (healthy controls).

All numbers in the square represent the pairwise D′ value as a percentile.

https://doi.org/10.1371/journal.pone.0190593.s001

(DOCX)

S1 Table. Characteristics of SNP markers on the SLC1A1 gene in controls.

https://doi.org/10.1371/journal.pone.0190593.s002

(DOCX)

S2 Table. Distribution of allelic and genotypic frequencies of SLC1A1 SNPs between male participants of OCD and control groups.

https://doi.org/10.1371/journal.pone.0190593.s003

(DOCX)

S3 Table. Distribution of allelic and genotypic frequencies of SLC1A1 SNPs between female participants of OCD and control groups.

https://doi.org/10.1371/journal.pone.0190593.s004

(DOCX)

S4 Table. The effects of SLC1A1 haplotype on affected status of OCD in male participants.

https://doi.org/10.1371/journal.pone.0190593.s005

(DOCX)

S5 Table. The effects of SLC1A1 haplotype on affected status of OCD in female participants.

https://doi.org/10.1371/journal.pone.0190593.s006

(DOCX)

S6 Table. The effects of SLC1A1 SNP on perspective taking score of IRI.

https://doi.org/10.1371/journal.pone.0190593.s007

(DOCX)

S7 Table. The effects of SLC1A1 SNP on fantasy seeking score of IRI.

https://doi.org/10.1371/journal.pone.0190593.s008

(DOCX)

S8 Table. The effects of SLC1A1 SNP on empathic concern score of IRI.

https://doi.org/10.1371/journal.pone.0190593.s009

(DOCX)

S9 Table. The effects of SLC1A1 SNP on personal distress score of IRI.

https://doi.org/10.1371/journal.pone.0190593.s010

(DOCX)

S10 Table. The effects of SLC1A1 haplotype on perspective taking score of IRI.

https://doi.org/10.1371/journal.pone.0190593.s011

(DOCX)

S11 Table. The effects of SLC1A1 haplotype on fantasy seeking score of IRI.

https://doi.org/10.1371/journal.pone.0190593.s012

(DOCX)

S12 Table. The effects of SLC1A1 haplotype on empathic concern score of IRI.

https://doi.org/10.1371/journal.pone.0190593.s013

(DOCX)

References

  1. 1. Stein DJ. The neurobiology of obsessive-compulsive disorder. Neuroscientist. 1996;2: 300–305.
  2. 2. Barr LC, Goodman WK, Price LH. The serotonin hypothesis of obsessive compulsive disorder. Int Clin Psychopharmacol. 1993;8 Suppl 2: 79–82.
  3. 3. Naaijen J, Lythgoe DJ, Amiri H, Buitelaar JK, Glennon JC. Fronto-striatal glutamatergic compounds in compulsive and impulsive syndromes: a review of magnetic resonance spectroscopy studies. Neurosci Biobehav Rev. 2015;52: 74–88. pmid:25712432
  4. 4. Chakrabarty K, Bhattacharyya S, Christopher R, Khanna S. Glutamatergic dysfunction in OCD. Neuropsychopharmacology. 2005;30: 1735–1740. pmid:15841109
  5. 5. Stryjer R, Budnik D, Ebert T, Green T, Polak L, Weizman S, et al. Amantadine augmentation therapy for obsessive compulsive patients resistant to SSRIs-an open-label study. Clin Neuropharmacol. 2014;37: 79–81. pmid:24824662
  6. 6. Pittenger C, Bloch MH, Wasylink S, Billingslea E, Simpson R, Jakubovski E, et al. Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a pilot randomized placebo-controlled trial. J Clin Psychiatry. 2015;76: 1075–1084. pmid:26214725
  7. 7. Rodriguez CI, Kegeles LS, Levinson A, Feng T, Marcus SM, Vermes D, et al. Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept. Neuropsychopharmacology. 2013;38: 2475–2483. pmid:23783065
  8. 8. Hanna GL, Veenstra-VanderWeele J, Cox NJ, Boehnke M, Himle JA, Curtis GC, et al. Genome-wide linkage analysis of families with obsessive-compulsive disorder ascertained through pediatric probands. Am J Med Genet. 2002;114: 541–552. pmid:12116192
  9. 9. Willour VL, Yao Shugart Y, Samuels J, Grados M, Cullen B, Bienvenu OJ 3rd, et al. Replication study supports evidence for linkage to 9p24 in obsessive-compulsive disorder. Am J Hum Genet. 2004;75: 508–513. pmid:15272418
  10. 10. Arnold PD, Sicard T, Burroughs E, Richter MA, Kennedy JL. Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder. Arch Gen Psychiatry. 2006;63: 769–776. pmid:16818866
  11. 11. Dickel DE, Veenstra-VanderWeele J, Cox NJ, Wu X, Fischer DJ, Van Etten-Lee M, et al. Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder. Arch Gen Psychiatry. 2006;63: 778–785. pmid:16818867
  12. 12. Shugart YY, Wang Y, Samuels JF, Grados MA, Greenberg BD, Knowles JA, et al. A family-based association study of the glutamate transporter gene SLC1A1 in obsessive-compulsive disorder in 378 families. Am J Med Genet B Neuropsychiatr Genet. 2009;150B: 886–892. pmid:19152386
  13. 13. Samuels J, Wang Y, Riddle MA, Greenberg BD, Fyer AJ, McCracken JT, et al. Comprehensive family-based association study of the glutamate transporter gene SLC1A1 in obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet. 2011;156B: 472–477. pmid:21445956
  14. 14. Stewart SE, Fagerness JA, Platko J, Smoller JW, Scharf JM, Illmann C, et al. Association of the SLC1A1 glutamate transporter gene and obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet. 2007;144B: 1027–1033. pmid:17894418
  15. 15. Wendland JR, Moya PR, Timpano KR, Anavitarte AP, Kruse MR, Wheaton MG, et al. A haplotype containing quantitative trait loci for SLC1A1 gene expression and its association with obsessive-compulsive disorder. Arch Gen Psychiatry. 2009;66: 408–416. pmid:19349310
  16. 16. Wu H, Wang X, Yu S, Wang D, Chen J, Jiang K, et al. Association of the candidate gene SLC1A1 and obsessive-compulsive disorder in Han Chinese population. Psychiatry Res. 2013;209: 737–739. pmid:23411042
  17. 17. Zhang K, Cao L, Zhu W, Wang G, Wang Q, Hu H, et al. Association between the efficacy of fluoxetine treatment in obsessive-compulsive disorder patients and SLC1A1 in a Han Chinese population. Psychiatry Res. 2015;229: 631–632. pmid:26154820
  18. 18. Stewart SE, Mayerfeld C, Arnold PD, Crane JR, O'Dushlaine C, Fagerness JA, et al. Meta-analysis of association between obsessive-compulsive disorder and the 3' region of neuronal glutamate transporter gene SLC1A1. Am J Med Genet B Neuropsychiatr Genet. 2013;162B: 367–379. pmid:23606572
  19. 19. Ryu S, Oh S, Cho EY, Nam HJ, Yoo JH, Park T, et al. Interaction between genetic variants of DLGAP3 and SLC1A1 affecting the risk of atypical antipsychotics-induced obsessive-compulsive symptoms. Am J Med Genet B Neuropsychiatr Genet. 2011;156B: 949–959. pmid:21990008
  20. 20. Kwon JS, Joo YH, Nam HJ, Lim M, Cho EY, Jung MH, et al. Association of the glutamate transporter gene SLC1A1 with atypical antipsychotics-induced obsessive-compulsive symptoms. Arch Gen Psychiatry. 2009;66: 1233–1241. pmid:19884611
  21. 21. Fontenelle LF, Soares ID, Miele F, Borges MC, Prazeres AM, Range BP, et al. Empathy and symptoms dimensions of patients with obsessive-compulsive disorder. J Psychiatr Res. 2009;43: 455–463. pmid:18614180
  22. 22. Kang JI, Namkoong K, Yoo SW, Jhung K, Kim SJ. Abnormalities of emotional awareness and perception in patients with obsessive-compulsive disorder. J Affect Disord. 2012;141: 286–293. pmid:22542863
  23. 23. Decety J, Moriguchi Y. The empathic brain and its dysfunction in psychiatric populations: implications for intervention across different clinical conditions. Biopsychosoc Med. 2007;1: 22. pmid:18021398
  24. 24. Pino MC, De Berardis D, Mariano M, Vellante F, Serroni N, Valchera A, et al. Two systems for empathy in obsessive-compulsive disorder: mentalizing and experience sharing. Rev Bras Psiquiatr. 2016;38: 307–313. pmid:27007147
  25. 25. Knafo A, Zahn-Waxler C, Van Hulle C, Robinson JL, Rhee SH. The developmental origins of a disposition toward empathy: Genetic and environmental contributions. Emotion. 2008;8: 737–752. pmid:19102585
  26. 26. Gong P, Fan H, Liu J, Yang X, Zhang K, Zhou X. Revisiting the impact of OXTR rs53576 on empathy: A population-based study and a meta-analysis. Psychoneuroendocrinology. 2017;80: 131–136. pmid:28343138
  27. 27. Wu N, Li Z, Su Y. The association between oxytocin receptor gene polymorphism (OXTR) and trait empathy. J Affect Disord. 2012;138: 468–472. pmid:22357335
  28. 28. Gong P, Liu J, Blue PR, Li S, Zhou X. Serotonin receptor gene (HTR2A) T102C polymorphism modulates individuals' perspective taking ability and autistic-like traits. Front Hum Neurosci. 2015;9: 575. pmid:26557070
  29. 29. Taschereau-Dumouchel V, Hetu S, Bagramian A, Labrecque A, Racine M, Chagnon YC, et al. BDNF Val66Met Polymorphism Is Associated with Self-Reported Empathy. PLoS One. 2016;11: e0149911. pmid:26901829
  30. 30. Duncan NW, Enzi B, Wiebking C, Northoff G. Involvement of glutamate in rest-stimulus interaction between perigenual and supragenual anterior cingulate cortex: a combined fMRI-MRS study. Hum Brain Mapp. 2011;32: 2172–2182. pmid:21305662
  31. 31. Montag C, Schubert F, Heinz A, Gallinat J. Prefrontal cortex glutamate correlates with mental perspective-taking. PLoS One. 2008;3: e3890. pmid:19060949
  32. 32. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR). 4th ed. Washington, DC: Amer Psychiatric Pub; 2000.
  33. 33. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry. 1989;46: 1006–1011. pmid:2684084
  34. 34. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134: 382–389. pmid:444788
  35. 35. Davis MH. Measuring individual differences in empathy: evidence for a multidimensional approach. Journal of Personality and Social Psychology. 1983;44: 113–126.
  36. 36. Kang I, Kee S, Kim SE, Jeong B, Hwang JH, Song JE, et al. Reliability and validity of the Korean-version of Interpersonal Reactivity Index. J Korean Neuropsychiatr Assoc. 2009;48: 352–358.
  37. 37. Cai J, Zhang W, Yi Z, Lu W, Wu Z, Chen J, et al. Influence of polymorphisms in genes SLC1A1, GRIN2B, and GRIK2 on clozapine-induced obsessive-compulsive symptoms. Psychopharmacology (Berl). 2013;230: 49–55. pmid:23660601
  38. 38. Real E, Gratacos M, Labad J, Alonso P, Escaramis G, Segalas C, et al. Interaction of SLC1A1 gene variants and life stress on pharmacological resistance in obsessive-compulsive disorder. Pharmacogenomics J. 2013;13: 470–475. pmid:22776887
  39. 39. Dallaspezia S, Mazza M, Lorenzi C, Benedetti F, Smeraldi E. A single nucleotide polymorphism in SLC1A1 gene is associated with age of onset of obsessive-compulsive disorder. Eur Psychiatry. 2014;29: 301–303. pmid:24768158
  40. 40. Gasso P, Ortiz AE, Mas S, Morer A, Calvo A, Bargallo N, et al. Association between genetic variants related to glutamatergic, dopaminergic and neurodevelopment pathways and white matter microstructure in child and adolescent patients with obsessive-compulsive disorder. J Affect Disord. 2015;186: 284–292. pmid:26254621
  41. 41. Gonzalez JR, Armengol L, Sole X, Guino E, Mercader JM, Estivill X, et al. SNPassoc: an R package to perform whole genome association studies. Bioinformatics. 2007;23: 644–645. pmid:17267436
  42. 42. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21: 263–265. pmid:15297300
  43. 43. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet. 2002;70: 425–434. pmid:11791212
  44. 44. Lee CK, Kwak YS, Yamamoto J, Rhee H, Kim YS, Han JH, et al. Psychiatric epidemiology in Korea. Part I: Gender and age differences in Seoul. J Nerv Ment Dis. 1990;178: 242–246. pmid:2319232
  45. 45. Ruscio AM, Stein DJ, Chiu WT, Kessler RC. The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry. 2010;15: 53–63. pmid:18725912
  46. 46. Brune CW, Kim SJ, Hanna GL, Courchesne E, Lord C, Leventhal BL, et al. Family-Based Association Testing of OCD-associated SNPs of SLC1A1 in an autism sample. Autism Res. 2008;1: 108–113. pmid:19360657
  47. 47. Gadow KD, Roohi J, DeVincent CJ, Kirsch S, Hatchwell E. Glutamate transporter gene (SLC1A1) single nucleotide polymorphism (rs301430) and repetitive behaviors and anxiety in children with autism spectrum disorder. J Autism Dev Disord. 2010;40: 1139–1145. pmid:20155310
  48. 48. Banissy MJ, Kanai R, Walsh V, Rees G. Inter-individual differences in empathy are reflected in human brain structure. Neuroimage. 2012;62: 2034–2039. pmid:22683384
  49. 49. Ernst J, Boker H, Hattenschwiler J, Schupbach D, Northoff G, Seifritz E, et al. The association of interoceptive awareness and alexithymia with neurotransmitter concentrations in insula and anterior cingulate. Soc Cogn Affect Neurosci. 2014;9: 857–863. pmid:23596189